Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer

Study ID: NCT05408260
Start Date: 2022-11-18
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Ultrasonography

Automated Breast Ultrasound

Sponsor

Thomas Jefferson University

Source: clinicaltrials.gov

Share:
Add to list

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Study ID: NCT03463460
Start Date: 2018-06-19
End Date: 2025-07-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Laboratory Biomarker Analysis

Pembrolizumab

Sunitinib Malate

Sponsor

Dwight Owen

Source: clinicaltrials.gov

Share:
Add to list

64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)

Study ID: NCT05633160
Start Date: 2023-06-15
End Date: 2026-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

38

Intervention / Treatment

64CU-SAR-BBN

67Cu-SAR-BBN

Sponsor

Clarity Pharmaceuticals Ltd

Source: clinicaltrials.gov

Share:
Add to list

A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

Study ID: NCT06106360
Start Date: 2023-10-26
End Date: 2025-11-26
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Locus Health iPhone App

Sponsor

Inova Health Care Services

Source: clinicaltrials.gov

Share:
Add to list

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Study ID: NCT05470491
Start Date: 2023-01-26
End Date: 2027-07-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

265

Intervention / Treatment

RIC

GVHD prophylaxis

allo HCT

Plerixafor

Marveloc

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Study ID: NCT04754191
Start Date: 2022-02-03
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

34

Intervention / Treatment

Emportumab Vedotin

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Study ID: NCT05150691
Start Date: 2022-01-31
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

796

Intervention / Treatment

DB-1303/BNT323

Pertuzumab Injection

Ritonavir

Itraconazole

Sponsor

DualityBio Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors

Study ID: NCT05593094
Start Date: 2020-10-15
End Date: 2026-10-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

210

Intervention / Treatment

ZN-A-1041 50mg BID

ZN-A-1041 100mg BID

ZN-A-1041 200mg BID

ZN-A-1041 400mg BID

ZN-A-1041 600mg BID

ZN-A-1041 800mg BID

ZN-A-1041 1000mg BID

ZN-A-1041 + T-DM1 3.6 mg/kg iv. for Phase1b

ZN-A-1041 + T-Dxd 5.4 mg/kg iv. for Phase1b

ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase1b

ZN-A-1041 + T-DM1 3.6 mg/kg iv. for Phase1c

ZN-A-1041 + T-Dxd 5.4 mg/kg iv. for Phase1c

ZN-A-1041 + PHESGO / Herceptin plus Perjeta injection for Phase1c

Sponsor

Suzhou Zanrong Pharma Limited

Source: clinicaltrials.gov

Share:
Add to list

Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts

Study ID: NCT04473794
Start Date: 2022-07-20
End Date: 2036-08-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5000

Intervention / Treatment
Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Trial of DFP-14927 in Advanced Solid Tumors

Study ID: NCT03943004
Start Date: 2019-09-30
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

DFP-14927

Sponsor

Delta-Fly Pharma, Inc.

Source: clinicaltrials.gov

Share:
Add to list